Effects of Celecoxib on Prostanoid Biosynthesis and Circulating Angiogenesis Proteins in Familial Adenomatous Polyposis-Reference-Cited by-同舟云学术

Effects of Celecoxib on Prostanoid Biosynthesis and Circulating Angiogenesis Proteins in Familial Adenomatous Polyposis

Published:2012-01-19 Issue:1 Volume:341 Page:242-250
ISSN:0022-3565
Container-title:Journal of Pharmacology and Experimental Therapeutics
language:en
Short-container-title:J Pharmacol Exp Ther

Author:

Dovizio Melania,Tacconelli Stefania,Ricciotti Emanuela,Bruno Annalisa,Maier Thorsten Jürgen,Anzellotti Paola,Di Francesco Luigia,Sala Paola,Signoroni Stefano,Bertario Lucio,Dixon Dan A.,Lawson John A.,Steinhilber Dieter,FitzGerald Garret A.,Patrignani Paola

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmacology,Molecular Medicine

Reference44 articles.

1. Hyperforin is a dual inhibitor of cyclooxygenase-1 and 5-lipoxygenase

2. The validation of self-reported smoking status by analysing cotinine levels in stimulated and unstimulated saliva, serum and urine

3. Biopharmaceutical characterisation of a low-dose (75 mg) controlled-release aspirin formulation;Charman;Br J Clin Pharmacol,1993

4. Radioimmunoassay of 11-dehydrothromboxane B2 in human plasma and urine;Ciabattoni;Biochim Biophys Acta,1987

5. Moderation of the platelet releasate response by aspirin

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Optimizing aspirin dose for colorectal cancer patients through deep phenotyping using novel biomarkers of drug action;Frontiers in Pharmacology;2024-02-29

2. Biomarkers of Response to Low-Dose Aspirin in Familial Adenomatous Polyposis Patients;Cancers;2023-04-25

3. Characterization of the acetylation of cyclooxygenase-isozymes and targeted lipidomics of eicosanoids in serum and colon cancer cells by the new aspirin formulation IP1867B versus aspirin in vitro;Frontiers in Pharmacology;2022-12-14

4. Inflammation and Cancer: From the Development of Personalized Indicators to Novel Therapeutic Strategies;Frontiers in Pharmacology;2022-03-03

5. Antiplatelet Agents Affecting GPCR Signaling Implicated in Tumor Metastasis;Cells;2022-02-18